TRANSCEND HEADACHE CLINIC
DEAD

Serial Number

98454009

Owner

Transcend Headache Clinic PLLC

Attorney

Thomas Kading

First Use Date

Mar 7, 2024

Filing Date

Mar 18, 2024

Add to watchlist:

No watchlists yet
View on USPTO

TRANSCEND HEADACHE CLINIC Trademark

Serial Number: 98454009

TRANSCEND HEADACHE CLINIC is a trademark filed by Transcend Headache Clinic PLLC on March 18, 2024. The trademark is classified under Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Transcend Headache Clinic PLLC

567 32nd Ave E, Ste. 201
West Fargo, ND 58078

Entity Type: 16

Trademark Details

Filing Date

March 18, 2024

Registration Date

Not Registered

First Use Anywhere

March 7, 2024

First Use in Commerce

March 7, 2024

Goods & Services

Health care services for treating migraines and headaches.; Health care services, namely, infusion therapy for migraines, nerve blocks, trigger point injections, Botox injections for migraine prophylaxis, and IM injections for abortive migraine treatment.; Health clinic services; Injectable botulinum toxin treatment services for medical purposes; Medical clinic services; Providing educational information about healthcare; Providing health information via a website

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 17, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 17, 2025 ABN2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 17, 2024 CHAN
ASSIGNED TO LIE
Dec 17, 2024 ALIE
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 17, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 17, 2024 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 1, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 1, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 1, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2024 NWOS
NEW APPLICATION ENTERED
Mar 18, 2024 NWAP